Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin
Research output: Contribution to journal › Letter › Research › peer-review
In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).
Translated title of the contribution | Successful treatment of KCNJ11 neonatal diabetes without insulin |
---|---|
Original language | Danish |
Article number | V08180547 |
Journal | Ugeskrift for Laeger |
Volume | 180 |
Issue number | 46 |
Number of pages | 2 |
ISSN | 0041-5782 |
Publication status | Published - 2018 |
Links
- http://ugeskriftet.dk/videnskab/succesfuld-behandling-af-kcnj11-neonatal-diabetes-uden-insulin
Final published version
ID: 219535295